Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Anemia, Sickle Cell × Glutamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 3 Peripheral Nervous System Diseases 2 Head and Neck Neoplasms 2 Vaso-Occlusive Crises 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Pain 1 Mucositis 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

voxelotor 1 maltodextrin 1 Glutamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Emmaus Medical, Inc.

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡